Immune Effector Cell-Associated Neurotoxicity Syndrome Related to Chimeric Antigen Receptor T-Cell Therapy

Neurology. 2024 Apr 23;102(8):e209266. doi: 10.1212/WNL.0000000000209266. Epub 2024 Mar 20.

Authors

Alejandro Herrero San Martin¹, Juan Alcala¹, Maialen Gonzalez¹, Gabriel Velilla Alonso¹, Guilherme Martins¹, Juan Romero Coronado¹

Affiliation

¹ From the Departments of Neurology (A.H.S.M., J.A., M.G., G.V.A.) and Radiology (G.M., J.R.C.), and Group of Neurodegenerative Diseases (A.H.S.M.), Investigation Institute, Hospital Universitario 12 de Octubre; and Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED) (A.H.S.M.), Madrid, Spain.

PMID: 38507663
DOI: 10.1212/WNL.0000000000209266

No abstract available

MeSH terms

Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive / adverse effects
Neurotoxicity Syndromes* / etiology
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen*

Substances

cell-associated neurotoxicity
Receptors, Chimeric Antigen
Receptors, Antigen, T-Cell